| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |